Juszczyk Jacek
Pol Merkur Lekarski. 2003 Apr;14(82):275-8.
This paper presents the results of clinical investigations of efficacy of consensus type interferon (Alfacon-1) in monotherapy, as well as in combination with ribavirin. A special indication for this kind of interferon are "difficult" patients with high virial load non-responders for previous treatment, as well as with recurrence of infection.
本文介绍了共识型干扰素(Alfacon-1)单药治疗以及与利巴韦林联合治疗的临床疗效研究结果。这类干扰素的一个特殊适应证是病毒载量高的“难治性”患者,这些患者对先前治疗无反应,且存在感染复发情况。